ArticleOncotarget2017
Methotrexate plus idarubicin improves outcome of patients with primary central nervous system lymphoma.
Ni Fan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleOncotarget2017
Ni Fan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.